Cartalax (Ala-Glu-Asp Tripeptide) – 20MG Research-Use-Only Peptide

Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED), belonging to a class of short peptide bioregulators originally developed for laboratory investigation of tissue-specific gene expression. This product is provided in a 20 mg vial formulation intended solely for controlled research environments.

Research Context

Short peptide bioregulators such as Cartalax were developed alongside related sequences (including tetrapeptide and dipeptide analogs) as tools for studying how brief amino acid sequences may influence gene expression in cultured cells. Cartalax is distinguished within this peptide class by its association with cartilaginous and connective tissue research models, in contrast to related short peptides studied in other tissue contexts. Published research specific to Cartalax remains limited relative to better-characterized peptides, and much of the available literature discusses the underlying AED sequence directly.

Research Overview

In vitro studies of AED-class short peptides have examined their effects on gene expression patterns in cultured cell models, including investigations into cytoskeletal and nuclear matrix protein expression. Researchers have used Cartalax and related sequences to explore tissue-specific differentiation signaling and cellular aging models in culture. These investigations remain exploratory and preclinical, and mechanism-of-action claims should be treated as hypotheses under active study rather than settled findings.

Key Research Focus Areas

• Gene Expression Modulation: Investigation of Cartalax’s influence on transcriptional activity in cultured cell models.
• Cytoskeletal and Nuclear Matrix Proteins: Study of short peptide effects on structural protein expression relevant to cell architecture.
• Connective Tissue Cell Models: Use in chondrocyte and related connective tissue cell culture systems to study tissue-specific signaling.
• Cellular Aging Research: Examination of AED-class peptides in mesenchymal stem cell aging culture models.
• Comparative Bioregulator Studies: Contrast with related short peptide sequences to clarify tissue-specificity and structure-function relationships.

Cautionary Statement

Cartalax is a research chemical and should only be handled by qualified personnel within approved academic or institutional research facilities. This product is not intended for human or animal consumption and poses significant risks if misused. Users must adhere to all applicable laboratory safety protocols, including proper disposal procedures for peptide waste. Always consult relevant institutional review boards and ethics committees prior to initiating research activities involving Cartalax.

For research use only. Not for human or animal consumption.